Increased plasma glucose levels after change of recommendation from NaF to citrate blood collection tubes.
Ridefelt P, Akerfeldt T, Helmersson-Karlqvist J
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of type of anticoagulant on plasma glucose measurements. Measurements from 460,751 specimens obtained over a 6 year period spanning the conversion from collection in Vacuette sodium fluoride tubes to collection in Terumo Venosafe tubes (containing sodium fluoride, citrate buffer and EDTA) were analyzed retrospectively.
Summary of Findings
Significantly higher glucose levels were measured after the change in recommendation from collection in sodium fluoride tubes to citrate tubes. Further, significantly higher percentages of specimens fell in the clinical range for diabetes and the range for impaired fasting glucose, as defined by World Health Organization (WHO) and American Diabetes Association (ADA), when citrate tubes were used for collection. The percentage of specimens falling in the hypoglycemic range decreased when citrate rather than sodium fluoride tubes were used for collection.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
Not specifiedPlatforms
CarbohydrateClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Citrate/sodium fluoride EDTASodium fluoride